Archives for July 2, 2006

← 2006

Israeli firm gearing up to make 'supergenerics'

By  Kirsty Barnes

Intec Pharma has enlisted two North American dosage form manufacturers to make "supergenerics" using its new method of oral drug delivery that can transform existing drugs into more powerful therapies.

BioPartners' biosimilar drug knocked back in Europe

By  Kirsty Barnes

BioPartners has failed to bring its second biosimilar product into Europe after the European Agency for the Evaluation of Medicinal Products (EMEA) issued a negative opinion on its hepatitis C drug, citing characterisation, manufacturing and quality...

Degussa unveils new excipient for poorly-flowing powders

By  Gregory Roumeliotis

Specialty chemicals firm Degussa has launched a new hydrophobic silica excipient which is particularly suitable for very hygroscopic and cohesive powders as it can significantly improve powder flow.

FDA's enforcement arm 'tied behind its back'

By  Gregory Roumeliotis

A report on the US Food and Drug Administration's (FDA) enforcement record by US Democratic lawmakers has highlighted a plunge in the number of warning letters the agency has sent to drug manufacturers since 2000, citing several examples where...